1. Home
  2. MEG vs SPRY Comparison

MEG vs SPRY Comparison

Compare MEG & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

N/A

Current Price

$25.86

Market Cap

966.4M

ML Signal

N/A

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

N/A

Current Price

$8.25

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MEG
SPRY
Founded
2012
2015
Country
United States
United States
Employees
3500
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
966.4M
1.0B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
MEG
SPRY
Price
$25.86
$8.25
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$35.25
$40.00
AVG Volume (30 Days)
452.9K
952.0K
Earning Date
05-28-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
93.69
N/A
EPS
N/A
N/A
Revenue
$830,538,000.00
$84,278,000.00
Revenue This Year
$4.94
$109.11
Revenue Next Year
$7.71
$91.00
P/E Ratio
N/A
N/A
Revenue Growth
19.26
N/A
52 Week Low
$10.51
$6.66
52 Week High
$32.00
$18.63

Technical Indicators

Market Signals
Indicator
MEG
SPRY
Relative Strength Index (RSI) 53.00 31.56
Support Level $24.39 $8.05
Resistance Level $27.44 $10.44
Average True Range (ATR) 1.41 0.46
MACD 0.03 -0.04
Stochastic Oscillator 50.09 7.41

Price Performance

Historical Comparison
MEG
SPRY

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, and soil remediation. The company derives maximum revenue from United States.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: